Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. This voice experience is generated by AI. Learn more. This voice ...

Abivax delivered outstanding phase 3 results for obefazimod in ulcerative colitis, with a 16.4% placebo-adjusted clinical remission rate. ABVX's safety profile is superior to JAK inhibitors and S1Ps, ...

For the lawyers in the billion-dollar M&A club, dealmaking is as much about stewardship as it is about strategy. Problem-solver, negotiator and even consigliere, they are trusted advisors to boards, ...

Johnson & Johnson’s $14.6 billion buyout of Intra-Cellular Therapies in the first month of 2025 suggested it would be a big year for high-priced transactions in the biopharma industry. But it was a ...